Arformoterol tartrate,
200815-49-2,
Brovana,
(R,R)-Formoterol tartrate,
(R,R)-Arformoterol tartrate,
UNII-5P8VJ2I235,
Formoterol tartrate,
Arformoterol Tartrate [USAN],
5P8VJ2I235,
Arformoterol tartrate (USAN),
Brovana Inhalation Solution,
Brovana (TN),
PubChem18307,
DTXSID80173903,
FCSXYHUNDAXDRH-OKMNHOJOSA-N,
(-)-N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide hydrogen (2R,3R)-2,3-dihydroxybutanedioate (salt),
Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt),
AKOS005145740,
API0007488,
SB17483,
Arformoterol tartrate, >=98% (HPLC),
AN-13010,
Z6130,
D02981,
815F492,
Q-101035,
(2R,3R)-2,3-dihydroxybutanedioic acid; N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]formamide,
(R,R)-Formoterol tartrate; N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1),
Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1),
N-(2-Hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1),
N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2R,3R)-2,3-dihydroxybutane dioate,
N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide (2R,3R)-2,3-dihydroxybutanedioate,
N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide L-tartrate,
Arformoteroltartrate,
(R,R)-Eformoterol tartrate,
C23H30N2O10,
C19H24N2O4.C4H6O6,
CB10250,
CID9827062,
CS-O-00839,
C19-H24-N2-O4.C4-H6-O6,
A12795,
Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt),